| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |